Valuation in Life Sciences

A Practical Guide

  • Boris Bogdan
  • Ralph Villiger

Table of contents

  1. Front Matter
    Pages i-xiii
  2. Dr. Boris Bogdan, Ralph Villiger
    Pages 1-9
  3. Dr. Boris Bogdan, Ralph Villiger
    Pages 11-65
  4. Dr. Boris Bogdan, Ralph Villiger
    Pages 67-303
  5. Dr. Boris Bogdan, Ralph Villiger
    Pages 305-329
  6. Dr. Boris Bogdan, Ralph Villiger
    Pages 331-361
  7. Back Matter
    Pages 363-370

About this book


This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including DCF, decision trees, and real options, the authors demonstrate how to value projects, patents, licences, firms, and stocks on real-life examples, even treating complex licence and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results.

The 3rd edition of the successful work includes new studies about success rates and about drug development in the biotech industry and their influence on valuation. 


Biotech Computerassistierte Detektion Medtech Pharma Radiologieinformationssystem Real Options Valuation Venture Capital biotechnology business development strategy

Authors and affiliations

  • Boris Bogdan
    • 1
  • Ralph Villiger
    • 2
  1. 1.AvanceBaselSwitzerland
  2. 2.AvanceBaselSwitzerland

Bibliographic information